Bridgebio Pharma, Inc.
BBIO
Revenue
2.17M
▼-208.95M▼-98.97%
3 Months ChangeAssets
794.38M
▼-54.96M▼-6.47%
3 Months ChangeLiabilities
1.88B
▼-9.72M▼-0.5155%
3 Months ChangeFree Cash Flow
-220.23M
▼-75.90M▼-52.58%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-11
Form 8-K
ID: 0001140361-24-040755
2024-08-21
Form 8-K
ID: 0001140361-24-037974
2024-08-01
Form 10-Q
ID: 0000950170-24-089326
2024-08-01
Form 8-K
ID: 0000950170-24-088952
2024-07-23
Form 8-K
ID: 0001140361-24-033856
2024-06-24
Form 8-K
ID: 0001140361-24-031087
2024-06-06
Form 8-K
ID: 0001140361-24-029050
2024-05-02
Form 10-Q
ID: 0000950170-24-052165
2024-05-02
Form 8-K
ID: 0000950170-24-051573
2024-03-06
Form 8-K
ID: 0001140361-24-011766